KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 101 filers reported holding KARUNA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,223,364 | +43.7% | 13,149 | +84.3% | 0.00% | +50.0% |
| Q2 2023 | $1,547,442 | -55.7% | 7,136 | -62.9% | 0.00% | -60.0% |
| Q1 2023 | $3,496,752 | -47.8% | 19,251 | -43.5% | 0.01% | -50.0% |
| Q4 2022 | $6,694,952 | -99.9% | 34,071 | -35.2% | 0.01% | -47.4% |
| Q3 2022 | $11,820,746,000 | +1496.9% | 52,553 | +798.2% | 0.02% | +1800.0% |
| Q2 2022 | $740,210,000 | +212.9% | 5,851 | +213.6% | 0.00% | – |
| Q1 2022 | $236,590,000 | -61.5% | 1,866 | -60.2% | 0.00% | -100.0% |
| Q4 2021 | $614,783,000 | +24.4% | 4,693 | +16.1% | 0.00% | 0.0% |
| Q3 2021 | $494,336,000 | +103.2% | 4,041 | +89.4% | 0.00% | – |
| Q2 2021 | $243,255,000 | +1.7% | 2,134 | +7.2% | 0.00% | – |
| Q1 2021 | $239,258,000 | +20.8% | 1,990 | +2.1% | 0.00% | – |
| Q4 2020 | $197,999,000 | -31.3% | 1,949 | -47.7% | 0.00% | – |
| Q3 2020 | $288,094,000 | +37.9% | 3,726 | +98.8% | 0.00% | – |
| Q2 2020 | $208,876,000 | -15.8% | 1,874 | -45.6% | 0.00% | -100.0% |
| Q1 2020 | $247,968,000 | +518.7% | 3,444 | +547.4% | 0.00% | – |
| Q4 2019 | $40,081,000 | +324.2% | 532 | -8.1% | 0.00% | – |
| Q3 2019 | $9,449,000 | – | 579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |